BCYC
Bicycle Therapeutics plc American Depositary Shares
PHARMACEUTICAL PREPARATIONS
Best Pharmaceutical Stocks 2026 →
Bicycle Therapeutics (BCYC) Stock: Buy, Sell, or Hold?
$3.49
-0.20 (-5.42%)
▼
5d:
+0.29%
30d:
-0.57%
90d:
-10.51%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (90%)
Quality Score
48/100
Position
OVERSOLD
30-Day Fair Range
$3.55 – $3.81
Position: OVERSOLD
Forward P/E & Valuation
-1.6x
Next 12M consensus est.
Wall Street Target
$9.17
+148.4% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$3.47 / $3.84
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: BCYC shows conflicting indicators. Wait for confirmation before entering.
Get Alerted When BCYC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: BCYC is currently trading at $3.49, which is considered oversold relative to its 30-day fair value range of $3.55 to $3.81.
Technical Outlook: Technically, BCYC is in a strong downtrend. The price is currently testing key support at $3.46. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 5.4% recently.
Market Sentiment: BCYC scores 66/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $9.17 (+148.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, BCYC is in a strong downtrend. The price is currently testing key support at $3.46. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 5.4% recently.
Market Sentiment: BCYC scores 66/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $9.17 (+148.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$3.55 -
$3.81
Company Quality Score
48/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
89.5%
Trading Range & Key Levels
30-Day Trading Range
$3.55 -
$3.81
Current vs Trading Range
OVERSOLD
Support Level
$3.47
Resistance Level
$3.84
Current Trend
Strong Downtrend
Technical data as of
Nov 12, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (66/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-5.4%)
- BULLISH: Trading 148.4% below Wall St target ($9.17)
- WARNING: Composite score 48/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-1.59
Wall Street Target
$9.17
(+148.4%)
Revenue Growth (YoY)
190.2%
Profit Margin
-169.8%
Share BCYC Analysis
Share this live BCYC analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (BCYC)
Bearish
1 Retail Mentions
Reddit / WSB Comments
1
Bearish
Last Tracked
Aug 18, 2024
Daily AI digest
AI Retail Discussion Summary:
Reddit & WallStreetBets discussions on BCYC are bearish (sentiment score -0.40) across 1 tracked comments.
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 2:21 PM ET
Data refreshes hourly during market hours. Next update: 3:21 PM
Data refreshes hourly during market hours. Next update: 3:21 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BCYC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
IONS
Ionis Pharmaceuticals Inc |
STRONG BUY
25 analysts |
$84 | 45 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 50 HOLD |
|
ABVX
Abivax SA American Depos… |
STRONG BUY
12 analysts |
$164 | 64 BUY |
|
STRO
Sutro Biopharma |
STRONG BUY
14 analysts |
$47 | 58 HOLD |
|
JANX
Janux Therapeutics Inc |
STRONG BUY
18 analysts |
$32 | 42 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive BCYC Research Pages
